Skip to Main Content

Paper Details

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Diabetes Care
28
2019
Advanced Nephropathy, Diabetic Nephropathy, ESRD, End-Stage Renal Disease, HbA1c, Patients, Type 1 Diabetes, advanced nephropathy, albumin, chronic kidney disease stages 1-3, creatinine, diabetic nephropathy, end-stage renal disease, macroalbuminuria, patient, patients, type 1 diabetes
Author NameAffiliation
Carol ForsblomFolkhalsan Institute of Genetics, Folkhalsan Research Center Abdominal Center, University of Helsinki and Helsinki University Hospital and Research Programs Unit, University of Helsinki
Michel MarreAssistance Publique des Hopitaux de Paris, Universite Denis Diderot Paris 7 and INSERM U8
Josyf C MychaleckyjCenter for Public Health Genomics, University of Virginia
Stephen S RichCenter for Public Health Genomics, University of Virginia
Samy HadjadjINSERM CIC 2 and U 1082
Samy HadjadjL'institut du thorax, CIC 3 INSERM
Per-Henrik GroopFolkhalsan Institute of Genetics, Folkhalsan Research Center Abdominal Center, University of Helsinki and Helsinki University Hospital and Research Programs Unit, University of Helsinki
Per-Henrik GroopCentral Clinical School, Monash University
  • 1 - 8

Datasets

Release 1.2